Replies to post #12240 on Mast Therapeutics, Inc. (MSTX)

[Rhodey Red]

Absolutely Trigger. Again, we could just be handed a rehash of completed Q2 events and more wet your appetite Q3-Q4 scheduled events, but for now I'll take anything official we can get from management. And the real sleeper in that listed group of events is the trauma model development. Getting a DOD sponsored program would be huge for us IMO. Speculating the potential financials of that indication for MST188 is too difficult right now, but the potential end customers are enormous.